Niva Bupa Health Insurance Company Stock Price - ₹80.73 | Insurance

‌
‌
‌

Company insights, generated from the most recent coverage.

Group health business growth is flat due to challenging B2B pricing, making retail expansion (which grew 47.1% in Q1 FY27) critical — now at risk from the 6-month branch expansion ban.
Retail loss ratio improved to 67.5% and solvency ratio stands at healthy 2.25x in Q1 FY27, providing a strong financial buffer despite regulatory headwinds.
Q1 FY27 GWP grew 31.7% YoY and PAT nearly doubled to ₹137.8 Cr, indicating strong underlying business momentum that contrasts with the short-term regulatory overhang.

‌
‌
‌

The Quarter story

The two most recent quarterly results, compared side-by-side.

Niva Bupa drives profitability and digital efficiency, though rising retail claims and a narrowing solvency buffer require attention.

Profit After Tax recovered from -₹91.4 Cr to ₹137.8 Cr from Q1 FY26 to Q1 FY27 — restoring bottom-line stability

Solvency Ratio declined from 2.86x to 2.25x from Q1 FY26 to Q1 FY27 — narrowing the capital buffer

Cashless claims auto adjudication rose from 12.5% to 38.4% from Q2 FY26 to Q1 FY27 — cutting manual review time

Retail Claims Ratio rose from 64.8% to 67.5% from Q2 FY26 to Q1 FY27 — pressuring retail underwriting margins

Individual Agent Count expanded from 193,555 to 251,834 from Q1 FY26 to Q1 FY27 — strengthening retail distribution

Broker channel share fell from 28.8% to 27.5% from Q1 FY26 to Q1 FY27 — shifting distribution weight

Claims Settlement Ratio climbed from 93.6% to 95.6% from Q1 FY26 to Q1 FY27 — maintaining high policyholder trust

Gross Written Premium peaked at ₹6,309.4 Cr in Q3 FY26 before moderating to ₹2,306.2 Cr in Q1 FY27 — reflecting normalized premium flows

Expense Ratio dropped from 39.1% to 37.2% from Q1 FY26 to Q1 FY27 — improving operational efficiency

‌
‌
‌

In the news

Niva Bupa, Acko barred from new offices for 6 months by IRDAI

Motilal Oswal sets Niva Bupa target at ₹103

Nifty 50 hits 24,429 high; Aarti Industries, Niva Bupa surge on heavy volumes

Niva Bupa raises FY27 marketing spend 40% with integrated strategy

Nomura picks Star Health, Niva Bupa for up to 23% upside

Niva Bupa shares surge 67% profit, Motilal Oswal targets ₹100

Niva Bupa appoints Ashwani Bhatia as new Chairperson

Motilal Oswal maintains ₹97 Niva Bupa target after strong Q4

Niva Bupa, Affle 3i, Birla Corp surge amid heavy volumes

Niva Bupa shares surge 10% on 67% Q4 profit jump to ₹345 crore

Niva Bupa Q4 profit jumps 67% to ₹345 cr, underwriting profit triples

Niva Bupa Q4 profit jumps 67% to ₹345 crore

55% of young health insurance buyers drop policies within 3 years

Niva Bupa gets IRDAI show cause notice after inspection

Motilal Oswal Maintains ₹92 Target on Niva Bupa Despite Q3 Challenges

Niva Bupa CEO: Retail Health Growth Needs More Investment

Niva Bupa Health Insurance posts Q3 net loss of ₹87.64 crore

Niva Bupa Health Insurance Company